Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $10.63 | N/A |
Market Cap | $214.91M | N/A |
Shares Outstanding | 20.22M | N/A |
Employees | 0 | N/A |